
Delia M. Ramirez
Examiner (ID: 4462)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 1518 |
| Issued Applications | 818 |
| Pending Applications | 200 |
| Abandoned Applications | 534 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19910453
[patent_doc_number] => 12286654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Base editing enzymes
[patent_app_type] => utility
[patent_app_number] => 17/841082
[patent_app_country] => US
[patent_app_date] => 2022-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 26
[patent_no_of_words] => 22835
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17841082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/841082 | Base editing enzymes | Jun 14, 2022 | Issued |
Array
(
[id] => 18093506
[patent_doc_number] => 20220411847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => GLUCOSE/GALACTOSE BIOSENSORS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/833763
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833763
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833763 | GLUCOSE/GALACTOSE BIOSENSORS AND METHODS OF USING SAME | Jun 5, 2022 | Abandoned |
Array
(
[id] => 18666156
[patent_doc_number] => 11773033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Bacterial consortia for enhancing conversion of organic soil phosphorous to orthophosphate and methods for making and using same
[patent_app_type] => utility
[patent_app_number] => 17/833492
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 35
[patent_no_of_words] => 11884
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833492
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833492 | Bacterial consortia for enhancing conversion of organic soil phosphorous to orthophosphate and methods for making and using same | Jun 5, 2022 | Issued |
Array
(
[id] => 18020953
[patent_doc_number] => 20220372452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => BIOCATALYSTS AND METHODS FOR THE SYNTHESIS OF ARMODAFINIL
[patent_app_type] => utility
[patent_app_number] => 17/833788
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833788
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833788 | Biocatalysts and methods for the synthesis of armodafinil | Jun 5, 2022 | Issued |
Array
(
[id] => 18148726
[patent_doc_number] => 20230022583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => ADIPATE (ESTER OR THIOESTER) SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/831011
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831011
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831011 | ADIPATE (ESTER OR THIOESTER) SYNTHESIS | Jun 1, 2022 | Abandoned |
Array
(
[id] => 17913566
[patent_doc_number] => 20220315961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/830650
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17830650
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/830650 | Engineered imine reductases and methods for the reductive amination of ketone and amine compounds | Jun 1, 2022 | Issued |
Array
(
[id] => 18229777
[patent_doc_number] => 20230068771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => EFFECTOR PROTEINS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/746851
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 163944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17746851
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/746851 | Effector proteins and methods of use | May 16, 2022 | Issued |
Array
(
[id] => 17960309
[patent_doc_number] => 20220340889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/745630
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745630
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745630 | Genetically engineered cells | May 15, 2022 | Issued |
Array
(
[id] => 17852194
[patent_doc_number] => 20220282236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => CREATININE DEIMINASE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/734169
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734169
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/734169 | CREATININE DEIMINASE AND USES THEREOF | May 1, 2022 | Abandoned |
Array
(
[id] => 17913560
[patent_doc_number] => 20220315955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => CARBON NEGATIVE PRODUCTION OF DIACIDS AND OTHER BIOCHEMICALS USING CELL FREE BIOCATALYSIS
[patent_app_type] => utility
[patent_app_number] => 17/713015
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2141
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713015
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/713015 | CARBON NEGATIVE PRODUCTION OF DIACIDS AND OTHER BIOCHEMICALS USING CELL FREE BIOCATALYSIS | Apr 3, 2022 | Pending |
Array
(
[id] => 20232731
[patent_doc_number] => 20250290050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-18
[patent_title] => MICROORGANISM HAVING ENHANCED ACTIVITY OF 3-METHYL-2-OXOBUTANOATE HYDROXYMETHYLTRANSFERASE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/776363
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776363
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776363 | MICROORGANISM HAVING ENHANCED ACTIVITY OF 3-METHYL-2-OXOBUTANOATE HYDROXYMETHYLTRANSFERASE AND USES THEREOF | Mar 17, 2022 | Pending |
Array
(
[id] => 17913235
[patent_doc_number] => 20220315630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => COMPOSITIONS AND METHODS FOR PRODUCING HIGH SECRETED YIELDS OF RECOMBINANT PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/695219
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695219
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695219 | Compositions and methods for producing high secreted yields of recombinant proteins | Mar 14, 2022 | Issued |
Array
(
[id] => 19158023
[patent_doc_number] => 20240150730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => NOVEL CITRATE SYNTHASE VARIANT AND METHOD FOR PRODUCING O-ACETYL-L-HOMOSERINE OR L-METHIONINE USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/279519
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279519
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279519 | NOVEL CITRATE SYNTHASE VARIANT AND METHOD FOR PRODUCING O-ACETYL-L-HOMOSERINE OR L-METHIONINE USING SAME | Mar 9, 2022 | Pending |
Array
(
[id] => 20207484
[patent_doc_number] => 20250277204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-04
[patent_title] => INSECT-DERIVED ASPARTATE DECARBOXYLASES AND VARIANTS THEREOF FOR IMPROVED BETA-ALANINE PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/548325
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548325
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548325 | INSECT-DERIVED ASPARTATE DECARBOXYLASES AND VARIANTS THEREOF FOR IMPROVED BETA-ALANINE PRODUCTION | Mar 2, 2022 | Pending |
Array
(
[id] => 20207484
[patent_doc_number] => 20250277204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-04
[patent_title] => INSECT-DERIVED ASPARTATE DECARBOXYLASES AND VARIANTS THEREOF FOR IMPROVED BETA-ALANINE PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/548325
[patent_app_country] => US
[patent_app_date] => 2022-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548325
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548325 | INSECT-DERIVED ASPARTATE DECARBOXYLASES AND VARIANTS THEREOF FOR IMPROVED BETA-ALANINE PRODUCTION | Mar 2, 2022 | Pending |
Array
(
[id] => 19142553
[patent_doc_number] => 20240141396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => ERGOTHIONEINE PRODUCTION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/548369
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548369
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548369 | ERGOTHIONEINE PRODUCTION METHOD | Feb 9, 2022 | Pending |
Array
(
[id] => 17609833
[patent_doc_number] => 20220152112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => NUCLEIC ACIDS ENCODING ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
[patent_app_type] => utility
[patent_app_number] => 17/589594
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17589594
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/589594 | NUCLEIC ACIDS ENCODING ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE | Jan 30, 2022 | Abandoned |
Array
(
[id] => 19505198
[patent_doc_number] => 12116610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-15
[patent_title] => Glycerol 3-phosphate oxidase mutants, compositions, devices, kits and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/585119
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8880
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17585119
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/585119 | Glycerol 3-phosphate oxidase mutants, compositions, devices, kits and uses thereof | Jan 25, 2022 | Issued |
Array
(
[id] => 19158094
[patent_doc_number] => 20240150801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => MUTANT OF CORYNEBACTERIUM GLUTAMICUM WITH ENHANCED L-CITRULLINE PRODUCTIVITY AND METHOD FOR PREPARING L-CITRULLINE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/280846
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4331
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280846
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/280846 | MUTANT OF CORYNEBACTERIUM GLUTAMICUM WITH ENHANCED L-CITRULLINE PRODUCTIVITY AND METHOD FOR PREPARING L-CITRULLINE USING THE SAME | Jan 18, 2022 | Pending |
Array
(
[id] => 17563177
[patent_doc_number] => 20220127326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/572018
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22005
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572018
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572018 | Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof | Jan 9, 2022 | Abandoned |